NanoCelle Introductory video - 2 min 40 sec runtime
NanoCelle® is a unique, patented delivery system with diverse applications.
QUICK FACTS
Improves compound solubility
Improves absorption
Reduces compound side effects
By-passes 1st pass metabolism
Improves Patient compliance
Improved onset
Significant in vitro and in vivo data
RESEARCH HAS SHOWN:
Extensive studies have been conducted, and results differ with different compounds, but over 400,000 NanoCelle® products have been dosed to patients with minimal side effects.
In vitro characterization done in collaboration with the University of Sydney
PK studies showed up too 5 times more compound is absorbed when compared to tablets, capsules, emulsions, and liposomes
Bioequivalence studies showed comparable levels to tablets 10x its dose.
Phase 1/2 studies showed safety, tolerability, and efficacy.
RWE Studies showed safety, tolerability, and efficacy over extended periods of time
The research portfolio showed no reported incident of CARPA.
Medlab Group PTY LTD
-
AU
-
2024On CPHI since
-
1 - 24Employees
Other Content from Medlab Group PTY LTD (1)
-
News MEDLAB GROUP - out-licencing and consultancy
Medlab Group is a private company specialising in delivery platforms, the human microbiome, and food supplement out-licencing.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance